Discontinued — last reported Q2 '23
Investing
Acquisitions
Year-over-year, this metric declined by 100.0%, from $7.44M to $0.00.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2016
Last reportedQ2 2023
How to read this metric
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
Detailed definition
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Peer comparison
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
Metric ID:
acquisitionsHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.44M | $294.00K | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -96.0% | -100.0% | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% |
Range$0.00 – $7.44M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Acquisitions at Other Companies
Frequently Asked Questions
- What is CRCL's acquisitions?
- CRCL (CRCL) reported acquisitions of $0.00 in Q1 2026.
- How has CRCL's acquisitions changed year-over-year?
- CRCL's acquisitions decreased by 100.0% year-over-year, from $7.44M to $0.00.
- What does acquisitions mean?
- Cash spent to acquire other companies or businesses, net of cash received in the deal.